Compass Pathways Plc (CMPS)
9.05
+0.67
(+8.00%)
USD |
NASDAQ |
Apr 30, 16:00
9.08
+0.03
(+0.33%)
After-Hours: 16:29
Compass Pathways EPS Diluted (Quarterly) : -1.001 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Definium Therapeutics, Inc. | -0.5106 |
| GH Research Plc | -0.2279 |
| Atai Beckley, Inc. | -1.734 |
| Nektar Therapeutics | -1.778 |
| Silence Therapeutics Plc | -0.0831 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -93.74M |
| Total Expenses (Quarterly) | 93.74M |
| Enterprise Value | 965.43M |
| Earnings Yield | -33.75% |
| Normalized Earnings Yield | -23.91 |